Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2001
01/10/2001EP1066320A1 Orphan nuclear receptor
01/10/2001EP1066319A1 Production methods and uses of a retrovirus
01/10/2001EP1066318A1 Nucleic acid molecules which code proteins influencing bone development
01/10/2001EP1066317A2 Novel compounds
01/10/2001EP1066315A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease
01/10/2001EP1066311A1 Compositions and methods for the identification of lung tumor cells
01/10/2001EP1066310A1 Neokine protein and nucleic acid molecules and uses therefor
01/10/2001EP1066309A1 Libraries of expressible gene sequences
01/10/2001EP1066060A2 Mesenchymal stem cells as immunosuppressants
01/10/2001EP1066057A1 Hemoglobin-polysaccharide conjugates
01/10/2001EP1066054A2 Use of active p40 conjugates for nasal delivery
01/10/2001EP1066051A1 Sciellin and uses thereof
01/10/2001EP1066050A2 Application of hsp70 proteins
01/10/2001EP1066045A1 Mammalian-derived peptides for the treatment of microbial infection
01/10/2001EP0946716A4 Waxy wheat starch types having waxy proteins in granule
01/10/2001EP0764209B1 Albumin expression in yeast
01/10/2001EP0730643B1 Transgenic animals harboring app allele having swedish mutation
01/10/2001EP0725797B1 Bivalent thrombin inhibitors
01/10/2001EP0701607B1 Preparation and use of transgenic mice lacking expression of cd28
01/10/2001CN1279723A Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
01/10/2001CN1279722A Gram-positive microorganism formate transporters
01/10/2001CN1279718A Fusion proteins comprising HIV-1 Tat and/or Nef proteins
01/10/2001CN1279716A Human gene Hsg 3
01/10/2001CN1279690A Soluble single-chain T-cell receptor proteins
01/10/2001CN1279689A Vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
01/10/2001CN1279288A Recombination human epidermal growth factor gene, its expression product and its application
01/10/2001CN1279110A In-colon release-controlled thymopeptide capsule and process for extracting and separating thymopeptide
01/10/2001CN1060521C Method for gene clone of inhibitory factor for hyperplasia of inner blood vessel cells in human body's real tumor, and using same to anti tumer blood vessel regeneration
01/09/2001US6172281 Generating eukaryotic cells expressing bacillus insect pesticide polypeptide; transfoming eukaryotic cells and expressing chimeric genes coding different pesticide polypeptides
01/09/2001US6172280 Bacterial resistance in grapevine
01/09/2001US6172279 Plant gene construct encoding a protein capable of disrupting the biogenesis of viable pollen
01/09/2001US6172278 Ikaros transgenic cells and mice
01/09/2001US6172277 Inducing amyloid plaque deposition in rodent brain; infusing brain of rodent with solution comprising amyloid peptide, detecting amplified amount of amyloid plaque formation in the brain of rodent compare to control
01/09/2001US6172226 Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
01/09/2001US6172211 Nucleotide sequences which codes a protein that modulates tumor propagation; for the treatment of cancer; antitumor agents; anticarcinogenic agents; antiproliferative agents
01/09/2001US6172210 Nucleotide sequences which code enzymatic protein associated with phosphatides; for reduction and prevention of fibrin coagulation and vascular thrombosis; for diagnosing coagulation defects
01/09/2001US6172203 Method for extracting and purifying pulmonary surfactant
01/09/2001US6172201 Cellular receptor for HIV-1 Vpr essential for G2/M phase
01/09/2001US6172200 Monoclonal antibody that preferentially binds protein; for use as diagnostic tool in analyzing embryonic development and cellular regulation; for the detection of modulators of gene expression
01/09/2001US6172198 Monoclonal antibody which binds to pregnancy associated plasma protein; for the detection of pereferential cancers and down's syndrome pregnancies
01/09/2001US6172196 Nucleotide sequences which express polypeptides useful in the production of alcholic beverages and baked goods
01/09/2001US6172195 Polypeptide associated with the modulation of signal transduction; for the diagnosis and treatment of defects in signal transduction
01/09/2001US6172194 ARF-p19, a novel regulator of the mammalian cell cycle
01/09/2001US6172193 Escape mutant of the surface antigen of hepatitis B virus
01/09/2001US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals
01/09/2001US6172191 Protein for inhibition and activation of protooncogene Ras and method for isolation thereof
01/09/2001US6172189 Polypeptide for the detection of antibodies associated with preferential viral diseases and infection
01/09/2001US6172188 Fluorescent proteins
01/09/2001US6172187 Mammalian polypeptide associated with immune response; for the modulation of apoptosis
01/09/2001US6172186 Pseudorabies virus protein
01/09/2001US6172185 Antimicrobial cationic peptide derivatives of bactenecin
01/09/2001US6172184 Genetically engineered protein; for generating disease resistance plants and to amplify plant propagation; for biological pest control
01/09/2001US6172047 Therapy for nervous system tumors
01/09/2001US6172042 Synthetic peptides that inhibit IL-6 activity
01/09/2001US6172041 Nervous system disorders
01/09/2001US6172040 Meat microbiocide
01/09/2001US6172039 Expression of recombinant hemoglobin and hemoglobin variants in yeast
01/09/2001US6172038 Antipathogenic peptides and compositions comprising them
01/09/2001US6171864 Nucleotide sequences coding calcium binding protein; for generation of disease and insect resistant plants
01/09/2001US6171859 Defective cytochrome c oxidase; diagnosing alzheimer*s disease
01/09/2001US6171857 Leucine zipper protein, KARP-1 and methods of regulating DNA dependent protein kinase activity
01/09/2001US6171854 Yellow fever infectious cDNA and plasmids
01/09/2001US6171846 Culturing cells which are blocked in the synthesis of virginimycins; mutating genes in target microorganism and recovering cells with mutated target genes
01/09/2001US6171838 ratB
01/09/2001US6171835 ribH
01/09/2001US6171827 Procollagens
01/09/2001US6171826 Methods of controlling beta dimer formation in hemoglobin
01/09/2001US6171825 Culturing mammalian host cells in medium supplemented with copper ions and free of plasma-derived protein and polyol supplements
01/09/2001US6171824 Polypeptide includes four alpha-helical and three linking sequences from leukemia inhibitory factor, granulocyte colony stimulating factor, interleukin-6, interleukin-11, ciliary neurotrophic factor, and oncostatin-m; therapy
01/09/2001US6171823 Transforming bacteria having cell membranes with recombinant vector encoding a fusion protein of n-terminal prepropeptide of acrhomobacter lyticus protease i fused to desired protein, culturing, and recovering proteins
01/09/2001US6171822 Stanniocalcin-2
01/09/2001US6171821 Screening for compounds which modulate cap-independent protein translation by exposing x-linked inhibitor of apoptosis internal ribosome entry site reporter cistron with test compound and determining change in amount of translation
01/09/2001US6171820 Saturation mutagenesis in directed evolution
01/09/2001US6171819 Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e.g. histidine) function
01/09/2001US6171818 Amino acid sequence of polypeptide from aplysia punctata, a sea snail; for recombinant production of anticarcinogenic agents
01/09/2001US6171816 Human XAG-1 polynucleotides and polypeptides
01/09/2001US6171815 Human sulfonylurea receptor
01/09/2001US6171807 Mixing together endotoxin neutralizing protein, urea, and fluorescein n-hydroxysuccinimide ester in an aqueous citrate buffer solution, and isolating the labeled protein; for use in testing
01/09/2001US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof
01/09/2001US6171805 Immunoassay diagnosis of periodontal disease by contacting serum sample with cell surface polypeptide of defined amino acid sequence and detecting antibodies which bind to polypeptide
01/09/2001US6171803 Drug screening for allergy treatments by engineering expression of alpha, beta, and gamma subunits of receptor in host cell, incubating with candidate inhibitor, and analyzing for cell expression or cell activation
01/09/2001US6171800 Method of making and binding CAIP polypeptides
01/09/2001US6171799 Immunoassay detection of a v beta 5.3 t cell by contacting tissue sample with a monoclonal antibody which reacts to variable region of beta chain of the receptor; diagnosis and treatment of rheumatoid arthritis
01/09/2001US6171792 Detection systems for registering protein interactions and functional relationships
01/09/2001US6171791 From the transmembrane receptor tyrosine kinase; for diagnosis of human cancer, especially of neural crest origin
01/09/2001US6171790 Human protease associated proteins
01/09/2001US6171788 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
01/09/2001US6171787 Detecting polynucleotide of tumor necrosis factor-gamma in sample by contacting with polynucleotide of defined nucleotide sequence and determining binding/hybridization; diagnosis of inflammation and related disorders
01/09/2001US6171783 Detecting parainfluenza virus-3 and respiratory syncytial virus infection by using fusion protein of antigenic proteins from both viruses
01/09/2001US6171782 Antibody compositions to HCV and uses thereof
01/09/2001US6171781 NF-AT polypeptides and polynucleotides
01/09/2001US6171779 HMGI proteins in cancer
01/09/2001US6171598 GTP cyclohydrolase II (RIBA)
01/09/2001US6171596 Immunostimulants; genetic engineering
01/09/2001US6171592 Equine rhinovirus 1 proteins
01/09/2001US6171591 Recombinant nodavirus compositions and methods
01/09/2001US6171590 Treatment and prevention of inflammatory responses.
01/09/2001US6171589 Are useful in protecting individuals against infections by species of the genus mycoplama.
01/09/2001US6171587 Antibodies to tissue factor inhibitor
01/09/2001US6171584 Method of treatment with growth/differentiation factors of the TGF-β family